GleamWall
中文EN

COR Cencora, Inc.

Wholesale-Drugs, Proprietaries & Druggists' Sundries · NYSE · SEC CIK 1140859 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.1%
TTM net income YoY38.3%
TTM EPS YoY38.3%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR15.8%

Margins

Gross margin4.0%
Operating margin0.9%
Net margin0.8%
FCF margin1.2%
EBITDA margin1.2%

Returns

ROE104.3%
ROA3.3%
ROIC (approx.)22.3%
Asset turnover4.22x

Leverage & solvency

Liabilities / assets96.1%
Debt / equity3.84x
Current ratio0.93x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.84x
Accruals ratio-2.8%
Payout ratio17.8%
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-09-30FY20242024-09-30
Income statement
Revenue$321.33B$293.96B
Cost of revenue$309.85B$284.05B
Gross profit$11.48B$9.91B
SG&A expense$6.49B$5.66B
Operating income$2.63B$2.18B
Pretax income$2.26B$2.00B
Income tax$690.52M$484.70M
Net income$1.55B$1.51B
EBITDA$3.68B$3.27B
EPS (basic)8.027.60
EPS (diluted)7.967.53
Dividends declared per share2.202.04
Weighted avg. shares (diluted)195.21M200.28M
Balance sheet
Cash & equivalents$4.36B$3.13B
Receivables$25.23B$23.87B
Inventory$20.49B$19.00B
Current assets$52.24B$47.72B
PP&E, net$2.54B$2.18B
Goodwill$13.68B$9.32B
Intangibles$3.77B$4.00B
Total assets$76.59B$67.10B
Current liabilities$57.82B$54.28B
Short-term debt$117.78M$576.33M
Long-term debt$7.54B$3.81B
Total debt$7.66B$4.39B
Total liabilities$74.84B$66.31B
Shareholders' equity$1.51B$645.94M
Net debt$3.30B$1.26B
Shares outstanding193.94M194.94M
Cash flow statement
Operating cash flow$3.88B$3.48B
Capital expenditure$667.98M$487.17M
Free cash flow$3.21B$3.00B
Investing cash flow-$4.98B-$618.10M
Financing cash flow$2.25B-$2.33B
Depreciation & amortization$1.05B$1.09B
Stock-based compensation$147.96M$148.00M
Dividends paid$437.08M$416.17M
Share buybacks$435.47M$1.49B

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.